Fig. 1 · Structure
Documents & Downloads
Droxidopa hydrochloride
Norepinephrine Precursor
Droxidopa hydrochloride is a potent orally active norepinephrine precursor. It effectively increases standing blood pressure and alleviates symptoms associated with orthostatic hypotension, thereby enhancing standing ability. This compound holds potential for research into neurogenic orthostatic hypotension (nOH) and may provide insights into alternative treatments for attention deficit hyperactivity disorder (ADHD).
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1260173-94-1 |
| Applications | Norepinephrine Precursor |
| Formula | C9H12ClNO5 |
| Molecular Weight | 249.65 |
| Synonyms | L-DOPS hydrochloride; DOPS hydrochloride; SM5688 hydrochloride |
| SMILES | OC1=C(O)C=CC([C@@H](O)[C@@H](C(O)=O)N)=C1.Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.